Pfizer ditches sweetened bid for Britain's AstraZeneca
2014-06-18 3
Pfizer withdrew its sweetened bid for AstraZeneca on Monday, ending a takeover saga that began back in January. The pharmaceutical giant's most recent bid for AstraZeneca, valued at £69.4 billion, or $117 billion, had received a mixed response from
